Short-term efficacy of argon-helium cryosurgery in treatment of advanced lung tumor
-
摘要:目的 评价氩氦刀冷冻治疗在晚期肺部肿瘤患者中的疗效。方法 选取因多种晚期肿瘤致肺部肿瘤的患者25例, 均行氩氦刀冷冻治疗。记录患者术前、术后CT图像测量肿瘤大小及密度值的变化，术后疼痛程度，并发症种类及发生率，以及患者的近期疗效。结果 氩氦刀治疗后，患者术后肿瘤CT测得值降低, 1个月后复查肿块明显缩小。患者并发症主要包括术后气胸、反应性胸腔积液、咯血、肺不张、发热等，并发症发生率较低。结论 氩氦刀治疗方案的术后疼痛轻微，并发症发生率较低，可以达到有效阻止肺部肿瘤进展，提高患者生存质量的目的。Abstract:Objective To evaluate the efficacy of argon-helium cryosurgery in treatment of advanced lung tumor.Methods Twenty-five patients with lung tumors caused by various advanced tumors were selected and treated with argon-helium cryosurgery. The changes of tumor size and density, the degree of postoperative pain, the types of complications and its incidence, and the short-term effect of patients were recorded.Results After argon-helium cryosurgery, the CT value of tumor decreased after operation, and the mass of tumor significantly reduced after one month of treatment. The complications mainly included postoperative pneumothorax, reactive pleural effusion, hemoptysis, atelectasis, fever and so on. The incidence rate of complications was low.Conclusion The postoperative pain of the argon-helium cryosurgery is mild, and the incidence of complications is low. Argon-helium cryosurgery can effectively prevent the progress of lung tumor and improve the quality of life of patients.
-
Keywords:
- argon-helium knife /
- lung neoplasm /
- cryosurgery /
- short-term efficacy
-
-
表 1 不同肿瘤直径患者手术前后CT值比较(x±s)
Hu 肿瘤直径 术前CT值 术后CT值 < 3.0 cm 23.37±14.63 -13.25±12.75 3.0~6.0 cm 35.62±8.38 -16.62±7.38 >6.0 cm 38.66±4.34 9.67±20.33 
下载: 导出CSV
-
[1] Lugnani F, Gunther E, Torrecillas P, et al. Cryoelectrolysis; an acute case study in the pig liver[J]. Cryobiology, 2017, 78: 110-114. doi: 10.1016/j.cryobiol.2017.08.001
[2] 冯华松, 黄友章, 段薀铀, 等. 氩氦刀冷冻处理的肺癌细胞增强树突状细胞有道抗肿瘤效应[J]. 生物医学工程研究, 2005, 24(2): 115-116. doi: 10.3969/j.issn.1672-6278.2005.02.015 [3] Browne B M, Vanni A J. Management of urethral stricture and bladder neck contracture following primary and salvage treatment of prostate cancer[J]. Curr Urol Rep, 2017, 18(10): 76-76. doi: 10.1007/s11934-017-0729-0
[4] 姚珂, 向明章, 闵家新, 等. Ⅲ期非小细胞肺癌术前新辅助化疗的随机对照临床试验[J]. 中国肿瘤临床, 2004, 31(11): 611-613. doi: 10.3969/j.issn.1000-8179.2004.11.004 [5] Mathur P N, Edell E, Sutedja T, et al. Treatment of early stage non-small cell lung cancer[J]. Chest, 2003, 123(1): 176S-180S. doi: 10.1378/chest.123.1_suppl.176S
[6] 苗劲柏, 侯生才, 李辉, 等. Ⅲa期非小细胞肺癌综合治疗方法的探讨[J]. 首都医科大学学报, 2007, 28(1): 104-106. doi: 10.3969/j.issn.1006-7795.2007.01.030 [7] Lucan V C, Lugnani F, Butticè S, et al. Cryotherapy for low risk prostate cancer, oncological and functional medium term outcomes: A three center prospective study[J]. Di, 2017, 89(2): 97-101. https://www.ncbi.nlm.nih.gov/pubmed/28679177
[8] Yamauchi Y, Izumi Y, Hashimoto K, et al. Percutaneous cryoablation for the treatment of medically inoperable stage Ⅰ non-small cell lung cancer[J]. PLOS One, 2012, 7(3): e33223-e33229. doi: 10.1371/journal.pone.0033223
[9] Yang Y, Lu Y, Wang C, et al. Cryotherapy is associated with improved clinical outcomes of Sorafenib therapy for advanced hepatocellular carcinoma[J]. Cell Biochem Biophys, 2012, 63(2): 159-169. doi: 10.1007/s12013-012-9353-2
[10] 赵海斌, 冯华松, 张绍强. CT引导下氩氦刀联合阿法替尼对肺腺癌患者的临床疗效研究[J]. 中国肿瘤外科杂志, 2019, 11(2): 116-120. doi: 10.3969/j.issn.1674-4136.2019.02.009 [11] 张富同, 李秀莉, 李慧杰, 等. 氩氦刀联合介入治疗复发、难治性非小细胞肺癌的临床分析[J]. 介入放射学杂志, 2007, 16(11): 759-761. doi: 10.3969/j.issn.1008-794X.2007.11.012
计量
- 文章访问数: 174
- HTML全文浏览量: 99
- PDF下载量: 12
苏公网安备 32100302010246号
